1910 Genetics announced a new five-year commercial agreement and go-to-market collaboration with Microsoft to harness advanced artificial intelligence and next-generation, high-performance computing to reverse 70 years of declining pharmaceutical R&D productivity.
February 29, 2024
· 8 min read
